HomeCereHealth Corporation

CereHealth Corporation

CereHealth Releases An Enhanced Version of Its Imaging Platform, CereMetrixai

Using its FDA-cleared QSPECT® analysis as a template, the platform can now incorporate additional imaging, such as MRI, PET and CT, and non-imaging analytical assessments through an expanding catalog of both in-house and third-party medical image algorithms.